Tom Luby Ph.D. is the Head of JLABS @ TMC in Houston, Texas. His responsibilities include external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. In this role, he catalyzes and support the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device and consumer healthcare sectors. Tom joined the Johnson & Johnson Innovation family 3 years ago as a New Ventures Lead at the Johnson & Johnson Innovation Center in Boston. In that role, he was instrumental in fostering many deals for the Boston office, which included the expansion of JLABS to JLABS @ Toronto. Prior to J&J, Tom spent 14 years in various R&D and business development positions, most recently as Sr. Director, Research Ventures at Shire. Nine of those years were spent working in R&D and operational roles across three start-up biotech companies in the Boston area. Tom received a Bachelor of Science in Biology from State University of New York, and a Ph.D. in Immunology from the Sackler School of Biomedical Sciences at Tufts University. For his post-doctoral research, Tom shifted to the study of cancer cell genetics at Harvard School of Public Health.